Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
Morie A GertzPublished in: American journal of hematology (2023)
Delayed diagnosis remains a major obstacle to initiating effective therapy prior to the development of end-stage organ failure. Trials of antibodies to deplete deposited fibrils are underway.